Lung Cancer Patients Live Longer With Immune Therapy

Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows. DENISE GRADY https://ift.tt/2qGky4b https://ift.tt/2H6vC5G The New York Times Health Immune System, Lung Cancer, Immunotherapy April 16, 2018 at 12:00AM